-+ 0.00%
-+ 0.00%
-+ 0.00%

Lucid Diagnostics Q3 Adj. EPS $(0.10) Beats $(0.11) Estimate, Sales $1.211M Miss $1.357M Estimate

Benzinga·11/12/2025 13:09:08
Listen to the news
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 50 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $1.211 million which missed the analyst consensus estimate of $1.357 million by 10.77 percent. This is a 3.33 percent increase over sales of $1.172 million the same period last year.